Home

Zeker Nominaal Worden teva news 2019 Gewoon overlopen als resultaat Typisch

Teva, workers sign accord on Jerusalem factory closure terms | The Times of  Israel
Teva, workers sign accord on Jerusalem factory closure terms | The Times of Israel

Drug maker Teva to fire 350 workers in efficiency bid for southern Israeli  plant | The Times of Israel
Drug maker Teva to fire 350 workers in efficiency bid for southern Israeli plant | The Times of Israel

Teva settles shareholder lawsuit over generic drug pricing for $420 mln |  Reuters
Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters

Teva Reports First Quarter 2020 Financial Results | Business Wire
Teva Reports First Quarter 2020 Financial Results | Business Wire

Teva CEO: Company would have gone bankrupt without layoffs - Business -  Haaretz.com
Teva CEO: Company would have gone bankrupt without layoffs - Business - Haaretz.com

Teva Crashes Following Purdue Pharma $10-$12 Billion Settlement Reports |  Ctech
Teva Crashes Following Purdue Pharma $10-$12 Billion Settlement Reports | Ctech

Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury  finds - JURIST - News
Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury finds - JURIST - News

Teva unloads plant, U.S. OTC line to PL Developments | FiercePharma
Teva unloads plant, U.S. OTC line to PL Developments | FiercePharma

18. Teva Pharmaceutical Industries | FiercePharma
18. Teva Pharmaceutical Industries | FiercePharma

Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg

US: 44 States Sue Pharmaceutical Company Teva for Price Fixing | News |  teleSUR English
US: 44 States Sue Pharmaceutical Company Teva for Price Fixing | News | teleSUR English

Teva Narrows Losses in 2019 – Business News From Israel
Teva Narrows Losses in 2019 – Business News From Israel

Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) |  Seeking Alpha
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha

Teva Restructuring Coming Together, Rebuilding Confidence in the Company |  BioSpace
Teva Restructuring Coming Together, Rebuilding Confidence in the Company | BioSpace

Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business  Wire
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire

Layoffs To Deepen As Teva Unveils New Structure And Leadership Changes -  Pharmaceutical Processing World
Layoffs To Deepen As Teva Unveils New Structure And Leadership Changes - Pharmaceutical Processing World

Teva Announces Collaboration with Publish Brand for Spring 2019
Teva Announces Collaboration with Publish Brand for Spring 2019

Teva Showcases Global Impact in 2019 Environmental, Social and Governance  Progress Report | Business Wire
Teva Showcases Global Impact in 2019 Environmental, Social and Governance Progress Report | Business Wire

Teva wins controversial PhRMA bid despite protests from branded rivals |  FiercePharma
Teva wins controversial PhRMA bid despite protests from branded rivals | FiercePharma

Teva Abandons Search to Make Covid-19 Vaccine for Partners - Bloomberg
Teva Abandons Search to Make Covid-19 Vaccine for Partners - Bloomberg

Teva Raises $2.1 Billion in Debt Tender Offer | Ctech
Teva Raises $2.1 Billion in Debt Tender Offer | Ctech

Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Pharmaceuticals found liable in New York opioid trial - BBC News

Teva Suffers Loss In New York's Opioid Trial
Teva Suffers Loss In New York's Opioid Trial

Pretax profit increases 13% to $364m at Irish arm of Teva
Pretax profit increases 13% to $364m at Irish arm of Teva

Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley  Fool
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool